Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

PMN-310 is under clinical development by ProMIS Neurosciences and currently in Phase I for Alzheimer’s Disease. According to GlobalData, Phase I drugs for Alzheimer’s Disease have a 63% phase ...

Hogue's final report was originally due at the end of last year but she was granted an extension. Catharine Tunney is a reporter with CBC's Parliament Hill bureau, where she covers national ...

executive producer with CBC Thunder Bay. In the video report, three individuals from the demonstration were interviewed, while zero seconds were given to anybody opposing the protest. Claims made by ...

Even the CBC’s own ombudsman is warning against relying entirely on the public broadcaster “if you want to be fully informed.” ...

Former House leader Karina Gould spent Friday and Saturday campaigning in Quebec but today is in Toronto working the phones, her campaign said. The only Liberal from Quebec vying for the leadership is ...

APS.TO Aptose Biosciences Inc.

CAMBRIDGE, Massachusetts, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and development of ...

The investigation into the deadliest air disaster on the country’s soil remains ongoing, the report made available on Monday said, focused on the role of “bird strike” and involving an ...